CYTOGRAFT TISSUE ENGINEERING, INC.

Company Information

Company Name
CYTOGRAFT TISSUE ENGINEERING, INC.
Address
3 HAMILTON LANDING, STE 220
NOVATO, CA, 94949-
Phone
1 415-506-0240
URL
n/a
DUNS
n/a
Number of Employees
n/a

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$736,896.00
5
SBIR Phase II
$3,955,796.00
2
Chart code to be here

Award List

  1. Cell-synthesized Thread-based Tissue Engineering

    Amount: $215,415.00

    DESCRIPTION (provided by applicant): Previously, we have reported excellent clinical results with a tissue engineered vascular graft built using a self-assembly approach termed Sheet-Based Tissue Eng ...

    SBIR Phase I 2010 Department of Health and Human Services
  2. Development of a Biological Stent Graft for Aorta Aneurysm Repair

    Amount: $214,912.00

    DESCRIPTION (provided by applicant): Abdominal aorta aneurysms (AAA) are diagnosed in more than 100,000 patients in the U.S. each year. About 70% of these patients require surgical intervention to pre ...

    SBIR Phase I 2010 Department of Health and Human Services
  3. N/A

    Amount: $98,880.00

    N/A

    SBIR Phase I 2000 Department of Health and Human Services
  4. Commercialization of a Tissue Engineered Blood Vessel

    Amount: $2,482,151.00

    DESCRIPTION (provided by applicant): The stated objective for this PA is to fund pre-clinical and clinical tests to support regulatory requirements for promising medical technologies. Accordingly, th ...

    SBIR Phase II 2005 Department of Health and Human Services
  5. in vivo Evaluation of a Tissue Blood Vessel

    Amount: $0.00

    DESCRIPTION (provided by applicant): Coronary heart disease is the leading cause of death in the industrialized world. Despite advances in catheter-based interventions, bypass remains the treatment ...

    SBIR Phase I 2003 Department of Health and Human Services
  6. Cell-synthesized Thread-based Tissue Engineering

    Amount: $1,473,645.00

    DESCRIPTION (provided by applicant): Cardiovascular disease is the leading cause of death in industrialized nations. While interventional techniques such as angioplasty and/or stenting can often dela ...

    SBIR Phase II 2011 Department of Health and Human Services
  7. Tau Protein Aggregation Inhibitors for Tauopathies

    Amount: $207,689.00

    DESCRIPTION (provided by applicant): Transcatheter aortic valve implantation (TAVI) is a minimally invasive approach to valve replacement that has had a rapid and profound clinical impact. Less than t ...

    SBIR Phase I 2013 Department of Health and Human Services

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government